Biologics Safety Testing Market Poised to Grow at a CAGR of 12.0% and 12.5% by 2023

Biologics Safety Testing Market Poised to Grow at a CAGR of 12.0% and 12.5% by 2023


Infinium Global Research has added a new report on Biologics Safety Testing Market. The report presents analysis of global as well as regional markets of biologics safety testing market over the period of 2015 to 2023. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global biologics safety testing market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2017-2023.

 

Get 15% discount for early purchase of global biologics safety testing market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/708

 

The recent report identified that North America dominated the global biologics safety testing market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the biologics safety testing market worldwide.

 

The report segments the global biologics safety testing market on the basis of Instruments and Services, Test Type and Application.

 

Global Biologics Safety Testing Market by Instruments and Services

·         Instruments

·         Services

·         Kits & Reagents

 

Global Biologics Safety Testing Market by Test Type

·         Bioburden Tests

·         Endotoxin Tests

·         Adventitious Agent Detection Tests

·         Cell Line Authentication And Characterization Tests

·         Sterility Tests

·          Residual Host Contaminant Detection Tests

·         Other Test Types

 

Global Biologics Safety Testing Market by Application

·         Vaccine & Therapeutics Development

·         Tissue And Tissue-Related Products Testing

·         Cellular And Gene Therapy

·         Blood And Blood-Related Products Testing

·         Stem Cell Research

 

Companies Profiled in the Report

·         Toxikon Corporation

·         Charles River Laboratories International, Inc.

·         Avance Biosciences Inc.

·         Thermo Fisher Scientific Inc.

·         Merck KGaA

·         Lonza Group Ltd.

·         Pace Analytical Services Inc.

·         Eurofins Scientific Se

·         Wuxi Apptec

·         Sartorius AG

·         Cytovance Biologics, Inc.

·         Source Bioscience

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.


© 2024. Infinium Global Research LLP. All Rights Reserved.